DNA methylation: A potential pathway to abnormal autoreactive lupus B cells

Clinical Immunology and Immunopathology

Volumn 80, Issue 1, 1996, Pages 1-8

  Huck, Sylvie ^a   Zouali, Moncef ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; DNA METHYLATION; HUMAN; NUCLEOSOME; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030199627     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0087     Document Type: Review

References (85)

1. 1. Boyden, S. V., Natural antibodies and the immune response. Adv. Immunol. 5, 1-28, 1966.
2. 2. Avrameas, S., Dighiero, G., Lymberi, P., and Guilbert, B., Studies on natural antibodies and autoantibodies. Ann. Immunol. 1, 103-113, 1983.
3. 3. Bhat, N. M., Kantor, A. B., Bieber, M. M., Stall, A. M., Herzenberg, L. A., and Teng, N. N., The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int. Immunol. 4, 243-252, 1992.
4. 4. Zouali, M., and Diamond, B., Idiotype-mediated intervention in systemic lupus erythematosus. J. Autoimmun. 3, 381-388, 1990.
5. 5. Tan, E. M., Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv. Immunol. 33, 167-240, 1982.
6. 6. Koffler, D., Agnello, V., Thoburn, R., and Kunkel, H. G., Systemic lupus erythematosus: Prototype of immune complex nephritis in man. J. Exp. Med. 134, 1971.
7. 7. Raz, E., Brezis, M., Rosenmann, E., and Eilat, D., Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J. Immunol. 142, 3076-3082, 1989.
8. 8. Zouali, M., Stollar, B. D., and Schwartz, R. S., Origin and diversification of anti-DNA antibodies. Immunol. Rev. 105, 137-159, 1988.
9. 9. Bhol, K., Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: A model for autoimmunity. Proc. Natl. Acad. Sci. USA 92, 5239-5243, 1995.
10. 10. Sabbaga, J., Line, S. R., Potocnjak, P., and Madaio, M. P., A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur. J. Immunol. 19, 137-143, 1989.
11. 11. Suzuki, N., Harada, T., Mizushima, Y., and Sakane, T., Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J. Immunol. 151, 1128-1136, 1993.
12. 12. Alarcon-Segovia, D., Rutz-Arguelles, A., and Fishbein, E., Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271, 67-69, 1978.
13. 13. Vlahakos, D. V., Foster, M. H., Ucci, A. A., Barrett, K. J., Datta, S. K., and Madaio, M. P., Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2, 1345-1354, 1992.
14. 14. Tsai, C. Y., Wu, T. H., Sun, K. H., Liao, T. S., Lin, W. M., and Yu, C. L., Polyclonal IgG anti-dsDNA antibodies exert cytotoxic effects on cultured rat mesangial cells by binding to cell membrane and augmenting apoptosis. Scand. J. Rheumatol. 22, 162-171, 1993.
15. 15. Nakamura, N., Shidara, Y., Kawaguchi, N., Azuma, C., Mitsuda, N., Onishi, S., Yamaji, K., and Wada, Y., Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: Involvement of annexin V. Biochem. Biophys. Res. Commun. 205, 1488-1493, 1994.
16. 16. Hurez, V., Dietrich, G., Kaveri, S. V., and Kazatchkine, M. D., Polyreactivity is a property of natural and disease-associated human autoantibodies. Scand. J. Immunol. 38, 190-196, 1993.
17. 17. Limpanasithikul, W., Ray, S., and Diamond, B., Cross-reactive antibodies have both protective and pathogenic potential. J. Immunol. 155, 967-973, 1995.
18. 18. Eilat, D., The role of germline gene expression and somatic mutation in the generation of autoantibodies to DNA. Mol. Immunol. 27, 203-210, 1990.
19. 19. Marion, T. N., Tillman, D. M., Jou, N. T., and Hill, R. J., Selection of immunoglobulin variable regions in autoimmunity to DNA. Immunol. Rev. 128, 123-149, 1992.
20. 20. Tsao, B. P., Ebling, F. M., Roman, C., Panosian-Sahakian, N., Calame, K., and Hahn, B. H., Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J. Clin. Invest. 85, 530-540, 1990.
21. 21. Shlomchik, M., Mascelli, M., Shan, H., Radic, M. Z., Pisetsky, D., Marshak-Rothstein, A., and Weigert, M., Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171, 265-292, 1990.
22. 22. Zouali, M., Development of human antibody variable genes in systemic autoimmunity. Immunol. Rev. 128, 73-99, 1992.
23. 23. Manheimer-Lory, A., Katz, J. B., Pillinger, M., Ghossein, C., Smith, A., and Diamond, B., Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype. J. Exp. Med. 174, 1639-1652, 1991.
24. 24. van Es, J. H., Gmelig Meyling, F. H., van de Akker, W. R., Aanstoot, H., Derksen, R. H., and Logtenberg, T., Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J. Exp. Med. 173, 461-470, 1991.
25. 25. Winkler, T. H., Fehr, H., and Kalden, J. R., Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur. J. Immunol. 22, 1719-1728, 1992.
26. 26. Demaison, C., Chastagner, P., Thèze, J., and Zouali, M., Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephritogenic anti-DNA idiotype. Proc. Natl. Acad. Sci. USA 91, 514-518, 1994.
27. 27. Chastagner, P., Demaison, C., Theze, J., and Zouali, M., Clonotypic dominance and variable gene elements of pathogenic anti-DNA autoantibodies from a single patient with lupus. Scand. J. Immunol. 39, 165-178, 1994.
28. 28. Zouali, M., and Theze, J., Probing VH gene-family utilization in human peripheral B cells by in situ hybridization. J. Immunol. 146, 2855-2864, 1991.
29. 29. Stewart, A. K., Huang, C., Stollar, B. D., and Schwartz, R. S., High-frequency representation of a single VH gene in the expressed human B cell repertoire. J. Exp. Med. 177, 409-418, 1993.
30. 30. Steinberg, A. D., Systemic lupus erythematosus: Theories of pathogenesis and approach to therapy. Clin. Immunol. Immunopathol. 72, 171-176, 1994.
31. 31. Rosen, A., Casciola-Rosen, L., and Ahearn, J., Novel packages of viral and self-antigens are generated during apoptosis. J. Exp. Med. 181, 1557-1561, 1995.
32. 32. Dong, X., Hamilton, K. J., Satoh, M., Wang, J., and Reeves, W. H., Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J. Exp. Med. 179, 1243-1252, 1994.
33. 33. Reininger, L., Radaszkiewicz, T., Kosco, M., Melchers, F., and Rolink, A. G., Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB × NZW)F1 pre-B cells. J. Exp. Med. 176, 1343-1353, 1992.
34. 34. Murakami, M., Yoshioka, H., Shirai, T., Tsubata, T., and Honjo, T., Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7, 877-882, 1995.
35. 35. Wen, L., Roberts, S. J., Viney, J. L., Wong, F. S., Mallick, C., Findly, R. C., Peng, Q., Craft, J. E., Owen, M. J., and Hayday, A. C., Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature 369, 654-658, 1994.
36. 36. Llorente, L., Zou, W., Levy, Y., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Morel-Fourrier, B., Brouet, J. C., Alarcon-Segovia, D., Galanaud, P., et al., Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181, 839-844, 1995.
37. 37. Goodnow, C. C., Crosbie, J. S., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, R. H., Raphael, K., Trent, R. J., and Basten, A., Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682, 1988.
38. 38. Hartley, S. B., Cooke, M. P., Fulcher, D. A., Harris, A. W., Cory, S., Basten, A., and Goodnow, C. C., Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell 72, 325-335, 1993.
39. 39. Chen, C., Nagy, Z., Radic, M. Z., Hardy, R. R., Huszar, D., Camper, S. A., and Weigert, M., The site and stage of anti-DNA B-cell deletion. Nature 373, 252-255, 1995.
40. 40. Lortan, J. E., Roobottom, C. A., Oldfield, S., and MacLennan, I. C., Newly produced virgin B cells migrate to secondary lymphoid organs but their capacity to enter follicles is restricted. Eur. J. Immunol. 17, 1311-1316, 1987.
41. 41. Chan, E. Y., and MacLennan, I. C., Only a small proportion of splenic B cells in adults are short-lived virgin cells. Eur. J. Immunol. 23, 357-363, 1993.
42. 42. Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Mason, D. Y., Jorgensen, H., Brink, R. A., Pritchard-Briscoe, H., Loughnan, M., et al., Clonal silencing of self-reactive B lymphocytes in a transgenic mouse model. Cold Spring Harb. Symp. Quant. Biol. 2, 907-920, 1989.
43. 43. Nemazee, D., Promotion and prevention of autoimmunity by B lymphocytes. Curr. Opin. Immunol. 5, 866-872, 1993.
44. 44. Russell, D. M., Dembic, Z., Morahan, G., Miller, J. F. A. P., Bürki, K., and Nemazee, D., Peripheral deletion of self-reactive B-cells. Nature 354, 308-310, 1991.
45. 45. Nemazee, D., Clonal deletion of autospecific B lymphocytes. Immunol. Rev. 122, 117-132, 1991.
46. 46. Tiegs, S. L., Russell, D. M., and Nemazee, D., Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177, 1009-1020, 1993.
47. 47. Pulendran, B., Kannourakis, G., Nouri, S., Smith, K. G., and Nossal, G. J., Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375, 331-334, 1995.
48. 48. Shokat, K. M., and Goodnow, C. C., Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375, 334-338, 1995.
49. 49. Cyster, J. G., Hartley, S. B., and Goodnow, C. C., Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 389-395, 1994.
50. 50. Gay, D., Saunders, T., Camper, S., and Weigert, M., Receptor editing: An approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177, 999-1008, 1993.
51. 51. Radic, M. Z., Erikson, J., Litwin, S., and Weigert, M., B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177, 1165-1173, 1993.
52. 52. Prak, E. L., Trounstine, M., Huszar, D., and Weigert, M., Light chain editing in kappa-deficient animals: A potential mechanism of B cell tolerance. J. Exp. Med. 180, 1805-1815, 1994.
53. 53. Prak, E. L., and Weigert, M., Light chain replacement: A new model for antibody gene rearrangement. J. Exp. Med., 1995.
54. 54. Tonegawa, S., Somatic generation of antibody diversity. Nature 302, 575-581, 1983.
55. 55. Zachau, H. G., The immunoglobulin kappa locus-or-what has been learned from looking closely at one-tenth of a percent of the human genome. Gene 135, 167-173, 1993.
56. 56. Pauza, M. E., Rehmann, J. A., and Le Bien, T. W., Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: Human B cells can simultaneously express cell surface kappa and lambda light chains. J. Exp. Med. 178, 139-149, 1993.
57. 57. Giachino, C., Padovan, E., and Lanzavecchia, A., kappa+lambda+ dual receptor B cells are present in the human peripheral repertoire. J. Exp. Med. 181, 1245-1250, 1995.
58. 58. Marolleau, J. P., Fondell, J. D., Malissen, M., Trucy, J., Barbier, E., Marcu, K. B., Cazenave, P. A., and Primi, D., The joining of germ-line V alpha to J alpha genes replaces the preexisting V alpha-J alpha complexes in a T cell receptor alpha, beta positive T cell line. Cell 55, 291-300, 1988.
59. 59. Borgulya, P., Kishi, H., Uematsu, Y., and von Boehmer, H., Exclusion and inclusion of alpha and beta T cell receptor alleles. Cell 69, 529-537, 1992.
60. 60. Chen, C., Radic, M. Z., Erikson, J., Camper, S. A., Litwin, S., Hardy, R. R., and Weigert, M., Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152, 1970-1982, 1994.
61. 61. Bensimon, C., Chastagner, P., and Zouali, M., Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J. 13, 2951-2962, 1994.
62. 62. Reap, E. A., Leslie, D., Abrahams, M., Eisenberg, R. A., and Cohen, P. L., Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol. 154, 936-943, 1995.
63. 63. Mysler, E., Bini, P., Drappa, J., Ramos, P., Friedman, S. M., Krammer, P. H., and Elkon, K. B., The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93, 1029-1034, 1994.
64. 64. Gatenby, P. A., and Irvine, M., The bcl-2 proto-oncogene is over-expressed in systemic lupus erythematosus. J. Autoimmun. 7, 623-631, 1994.
65. 65. Aringer, M., Wintersberger, W., Steiner, C. W., Kiener, H., Presterl, E., Jaeger, U., Smolen, J. S., and Graninger, W. B., High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum. 37, 1423-1430, 1994.
66. 66. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. D., Protection from fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762, 1994.
67. 67. Emlen, W., Niebur, J., and Kadera, R., Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152, 3685-3692, 1994.
68. 68. Bell, D. A., Morrison, B., and Vanden Bygaart, P., Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85, 1487-1496, 1990.
69. 69. Mohan, C., Adams, S., Stanik, V., and Datta, S. K., Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177, 1367-1381, 1993.
70. 70. Amoura, Z., Chabre, H., Koutouzov, S., Lotton, C., Cabrespines, A., Bach, J. F., and Jacob, L., Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37, 1684-1688, 1994.
71. 71. Sano, H., Takai, O., Harata, N., Yoshinaga, K., Kodama-Kamada, I., and Sasaki, T., Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand. J. Immunol. 30, 51-63, 1989.
72. 72. Sano, H., Imokawa, M., Steinberg, A. D., and Morimoto, C., Accumulation of guanine-cytosine-enriched low M.W. DNA fragments in lymphocytes of patients with systemic lupus erythematosus. J. Immunol. 130, 187-190, 1983.
73. 73. Corvetta, A., Della Bitta, R., Luchetti, M. M., and Pomponio, G., 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases. J. Chromatogr. 566, 481-491, 1991.
74. 74. Richardson, B. C., Liebling, M. R., and Hudson, J. L., CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation. Clin. Immunol. Immunopathol. 55, 368-381, 1990.
75. 75. Quddus, J., Johnson, K. J., Gavalchin, J., Amento, E. P., Chrisp, C. E., Yung, R. L., and Richardson, B. C., Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92, 38-53, 1993.
76. 76. Yung, R. L., Quddus, J., Chrisp, C. E., Johnson, K. J., and Richardson, B. C., Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154, 3025-3035, 1995.
77. 77. Hess, E., Drug-related lupus. N. Engl. J. Med. 318, 1460-1462, 1988.
78. 78. Yung, R. L., and Richardson, B. C., Drug-induced lupus. Rheum. Dis. Clin. North Am. 20, 61-86, 1994.
79. 79. Doerfler, W., DNA methylation and gene activity. Annu. Rev. Biochem. 52, 93-124, 1983.
80. 80. Goodhardt, M., Cavelier, P., Doyen, N., Kallenbach, S., Babinet, C., and Rougeon, F., Methylation status of immunoglobulin kappa gene segments correlates with their recombination potential. Eur. J. Immunol. 23, 1789-1795, 1993.
81. 81. Rekvig, O. P., Fredriksen, K., Brannsether, B., Moens, U., Sundsfjord, A., and Traavik, T., Antibodies to eukaryotic, including autologous, native DNA are produced during BK virus infection, but not after immunization with non-infectious BK DNA. Scand. J. Immunol. 36, 487-495, 1992.
82. 82. Desai, D. D., Krishnan, M. R., Swindle, J. T., and Marion, T. N., Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J. Immunol. 151, 1614-1626, 1993.
83. 83. Gilkeson, G. S., Bloom, D. D., Pisetsky, D. S., and Clarke, S. H., Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Differences from spontaneous anti-DNA in the content and location of VH CDR3 arginines. J. Immunol. 151, 1353-1364, 1993.
84. 84. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M., CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549, 1995.
85. 85. Krieg, A. M., CpG DNA: A pathogenic factor in systemic lupus erythematosus. J. Clin. Immunol. 15, 284-292, 1995.